학술논문

Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study
Document Type
Article
Source
In: Neurological Sciences. (Neurological Sciences, November 2022, 43(11):6415-6423)
Subject
Language
English
ISSN
15903478
15901874